Evidence map›Paper›PMID 26909253›Full record

ReviewJournal of bone oncology2012

The Italian cross-sectional survey of the management of bone metastasis: ZeTa study.

Daniele Santini, Francesco Bertoldo, Emanuela Dell'Aquila, Isabella Cecchini, Stefania Fregosi, Paolo Bortolussi, ZeTa study group

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of bone oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniele SantiniOncologia Medica, University Campus Biomedico, Roma, Rome, Italy.
Francesco BertoldoDepartment of Medicine, University of Verona, Verona, Italy.
Emanuela Dell'AquilaOncologia Medica, University Campus Biomedico, Roma, Rome, Italy.
Isabella CecchiniGfK Eurisko, Milan, Italy.
Stefania FregosiGfK Eurisko, Milan, Italy.
Paolo BortolussiGfK Eurisko, Milan, Italy.
ZeTa study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral studies have emphasized the importance of the maintenance of bone health in a comprehensive cancer care. However, no survey about approach to bone metastasis care is currently available. The ZeTa study provides a picture of the Italian oncologists' therapeutics habits in this area, in a real clinical-practice scenario.

designThis study was based on online questionnaire-based interviews to Italian oncologists that included 145 questions. The aim was to collect information on the treatment of bone metastasis, the current use of bisphosphonates, the awareness of guidelines and the concerns about ONJ, the use of vitamin D supplementation.

results445 oncologists were contacted, 283 agreed to participate. The results show that the current management of bone metastasis is still sub-optimal, as the recommendations from current clinical guidelines are not completely followed by all specialists.

conclusionsThis survey highlights the urgent need to improve management of bone metastasis in cancer patients.

Indexed as

BisphosphonateBone metastasisSkeletal-related eventSurvey

Identifiers

PMID26909253
PMCPMC4723326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.